ATNT-19TUMOR TREATING FIELDS WITH CHEMOTHERAPY COMPARED TO CHEMOTHERAPY ALONE IN GLIOBLASTOMA PATIENTS AT FIRST RECURRENCE: A POST-HOC ANALYSIS OF THE EF-14 TRIAL | Zendy

AI Assistant Blog Pricing

ATNT-19TUMOR TREATING FIELDS WITH CHEMOTHERAPY COMPARED TO CHEMOTHERAPY ALONE IN GLIOBLASTOMA PATIENTS AT FIRST RECURRENCE: A POST-HOC ANALYSIS OF THE EF-14 TRIAL

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.